| Literature DB >> 32450799 |
Eva-Maria Saliu1, Jürgen Zentek2, Wilfried Vahjen2.
Abstract
BACKGROUND: Extended spectrum beta-lactamase (ESBL)-producing enterobacteria pose a major hazard to public health. Due to the possibility of genetic transfer, ESBL genes might spread to pathogenic enterobacterial strains. Thus, information on possible genetic transfer between enterobacteria is of high interest. It was therefore the aim of this in vitro study to screen the capacity of a wide range of Enterobacteriaceae for differences in conjugation at different time points with five ESBL-producing Escherichia coli strains.Entities:
Keywords: Antibiotic resistance; ESBL; Extended-spectrum ß-lactamases; Horizontal gene transfer; Poultry
Mesh:
Substances:
Year: 2020 PMID: 32450799 PMCID: PMC7249311 DOI: 10.1186/s12866-020-01787-7
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Screening for conjugation
| Donor | |||||
|---|---|---|---|---|---|
| + | + | nd | nd | + | |
| + | – | nd | nd | + | |
| + | nd | + | nd | nd | |
| + | + | – | – | nd | |
| – | – | + | – | + | |
| – | – | – | – | – |
Nd not determined, + = bacterial growth, − = no growth/< 5 colonies
Conjugation frequencies of selected donor- and recipient strains [log10transconjugants/donor]
| Donor | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Recipient | |||||||||||
| 0 h | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT |
| 2 h | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT | NT |
| 4 h | −7.00 | NT | −4.98 | −5.74 | −7.26 | NT | NT | NT | NT | NT | NT |
| 6 h | −6.62 | NT | −6.27 | −7.05 | −7.30 | NT | NT | NT | NT | NT | NT |
| 8 h | −6.70 | NT | −5.91 | −6.71 | −8.48 | − 6.91 | NT | NT | NT | NT | NT |
| 22 h | −6.78 | −6.52 | −5.92 | −7.26 | − 6.45 | −6.98 | − 5.86 | −5.70 | −6.80 | − 6.25 | −6.49 |
NT no transconjugants; experiments were performed in duplicates and the results were reported as their average (coefficients of variation < 10.6%)
Antibiotic resistance and susceptibility of the potential donor and recipient strains from disc diffusion test
| Bacteria | Indication | AK 30 μg | CN 30 μg | TOB 10 μg | ENR 5 μg | MAR 50 μg | F 300 μg | C 30 μg | CT 25 μg | PB300 IE | RD 30 μg | SXT 25 μg | CTX30 μg | CEFT 30 μg | CL 30 μg | CPD 10 μg | CTX 5 μg | IPM 10 μg | MEM 10 μg | CIP 5 μg | FOS 50 μg | TGC 15 μg |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMT 20751/402 | S | S | (R) | R | R | S | R | S | S | S | R | S | S | R | R | x | S | S | S | S | S | |
| IMT11716 | S | S | S | S | S | S | R | S | S | S | S | S | S | S | S | x | S | S | S | S | S | |
| L1219-R32 | S | S | S | S | S | S | S | S | S | S | R | S | S | S | S | x | S | S | S | S | S | |
| DSM 30122 | S | S | S | S | S | S | S | R | R | S | S | S | S | R | S | x | S | S | S | S | S | |
| ESBL | ESBL 10682 | S | S | S | S | S | S | S | S | S | S | S | S | ? | R | R | x | x | x | x | x | x |
| ESBL | ESBL 10689 | S | S | S | S | S | S | S | S | S | S | R | S | S | S | R | x | x | x | x | x | x |
| ESBL | ESBL 10708 | S | S | S | S | S | S | (R) | S | S | S | S | S | S | R | R | x | x | x | x | x | x |
| DSM 30060 | S | S | S | S | S | (R) | S | S | S | S | S | x | x | x | x | S | S | S | S | S | S | |
| ESBL | ESBL 10716 | S | R | R | R | R | S | R | S | S | x | R | R | R | R | R | R | S | S | R | S | S |
| ESBL | ESBL 10717 | S | S | S | S | S | I | S | R | R | x | S | R | R | R | R | R | S | S | S | S | S |
Abbreviations: S sensitive, R resistant, x not tested
Antibiotic substances and concentrations: Amikacin (AK) 30 μg, Chloramphenicol (C) 30 μg, Cefitofur (CEFT) 30 μg, Ciprofloxacin (CIP) 5 μg, Cephalexime (CL) 30 μg, Gentamycin (CN) 30 μg, Cefpodoxime (CPD) 10 μg, Colistin (CT) 25 μg, Cefotaxime (CTX) 30 μg, Cefotaxime (CTX) 5 μg, Enrofloxacin (ENR) 5 μg, Nitrofurantoin (F) 300 μg, Fosfomycin (FOS) 50 μg, Imipenem (IPM) 10 μg, Marbofloxacin (MAR) 5 μg, Meropenem (MEM) 10 μg, Polymyxin (PB) 300 IE, Rifampicin (RD) 30 μg, Sulfamethoxazol/ Trimethoprim (SXT) 25 μg, Tigecycline (TGC) 15 μg, Tobramycin (TOB) 10 μg